在未来的多中心队列中预测急性严重性结肠炎住院患者的预测结果
Lara Chaaban1, Benjamin Cohen2,3, Raymond K Cross4
1Division of Gastroenterology and Hepatology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Inflammatory bowel diseases
|October 17, 2024
概括
低的BMI,高的简单临床大肠炎活动指数 (SCCAI) 和低的白蛋白预测严重性大肠炎 (UC) 患者的胆管切除术. 识别高风险个体对于更好的急性严重UC (ASUC) 治疗策略至关重要.
科学领域:
- 胃肠病学 胃肠病学
- 炎症性肠道疾病研究研究
- 临床结果研究研究
背景情况:
- 需要住院治疗的急性严重性结肠炎 (ASUC) 影响了相当一部分UC患者.
- 有限的前性,多中心数据存在于ASUC的治疗趋势和结果预测指标.
- 这项研究解决了需要强大的临床队列来了解ASUC管理的需求.
研究的目的:
- 在住院ASUC患者中确定医疗救援疗法和胆管切除术的预测因子.
- 分析美国多中心前景临床队列中的治疗趋势.
- 在ASUC建立新的治疗范式的基础.
主要方法:
- 在5个学术中心建立了一个由94名为ASUC住院的患者组成的前性多中心队列.
- 数据收集包括住院期间的人口统计,临床因素和实验室值.
- 患者在住院后被跟踪长达1年,以确定胆管切除术预测因素.
主要成果:
- 在1年内,22.3%的患者需要进行大肠切除术,12%的患者在初次入院期间进行了大肠切除术.
- 多变量分析确定BMI<21.5 kg/m2 (OR=6.16),SCCAI>8 (OR=14.44),和白蛋白<2.4 g/dL (OR=10.61) 作为住院科切除术的显著预测因素.
- 这些预测因素在调整性别,年龄和疾病持续时间后仍然显著.
结论:
- 体重指数,SCCAI和入院白蛋白水平是ASUC中胆管切除风险的关键决定因素.
- 高的胆管切除率 (22.3%) 凸显了改善风险分层和标准化护理的需要.
- 进一步的研究应该集中在识别高风险患者和开发新的治疗策略上.
相关概念视频
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
331
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
331
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
160
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
160
01:21Inflammatory Bowel Disease V: Surgical Management
134
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
134
01:29Drugs for Treatment of Ulcerative Colitis in IBD
131
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
131
01:28Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
101
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
101
01:26Peptic Ulcer Disease IV: Management
78
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
78